APA (7th ed.) Citation

Shalata, W., Yakobson, A., Dudnik, Y., Swaid, F., Ahmad, M. S., Jama, A. A., . . . Agbarya, A. (2023). Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Shalata, Walid, Alexander Yakobson, Yulia Dudnik, Forat Swaid, Mohammad Sheikh Ahmad, Ashraf Abu Jama, Ahron Yehonatan Cohen, and Abed Agbarya. Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer. MDPI AG, 2023.

MLA (9th ed.) Citation

Shalata, Walid, et al. Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer. MDPI AG, 2023.